Milrinone Horizon 10mg/10 mL Concentrated Injection milrinone (as lactate)10mg/10 mL ampoule

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

milrinone, Quantity: 10 mg

Tillgänglig från:

Generic Health Pty Ltd

INN (International namn):

Milrinone

Läkemedelsform:

Injection, concentrated

Sammansättning:

Excipient Ingredients: water for injections; lactic acid; sodium hydroxide; glucose

Administreringssätt:

Intravenous

Enheter i paketet:

10 ampoules, 1 ampoule

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

- Milrinone Horizon Concentrated Injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (eg. digoxin, diuretics, vasodilators, including ACE inhibitors). The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. - Milrinone Horizon Concentrated Injection is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Produktsammanfattning:

Visual Identification: Clear, colourless to pale yellow sterile solution, practically free from visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Bemyndigande status:

Licence status A

Tillstånd datum:

2013-11-29